Glinide [EPC]

Glinide [EPC] was reported 8904 times

Drugs of the Glinide [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS 12 0.9231
1 PROTHROMBIN CONSUMPTION TIME PROLONGED 9 0.5625
2 ANTI FACTOR V ANTIBODY 12 0.4286
3 POLYMERASE CHAIN REACTION 8 0.0708
4 CONGENITAL UTERINE ANOMALY 6 0.0550
5 HYPOGLYCAEMIC COMA 141 0.0489
6 BENIGN PANCREATIC NEOPLASM 7 0.0368
7 HYPOGLYCAEMIC ENCEPHALOPATHY 13 0.0334
8 GASTRODUODENAL ULCER 14 0.0333
9 SWEAT GLAND TUMOUR 7 0.0298
10 RENAL ARTERIOSCLEROSIS 6 0.0246
11 OESOPHAGEAL PERFORATION 20 0.0240
12 CHRONIC GASTROINTESTINAL BLEEDING 5 0.0196
13 POVERTY OF SPEECH 7 0.0179
14 SOFT TISSUE NECROSIS 12 0.0175
15 HYPOGLYCAEMIA 836 0.0172
16 FAECAL VOMITING 9 0.0169
17 PENIS INJURY 6 0.0167
18 GINGIVAL ABSCESS 12 0.0159
19 MECHANICAL URTICARIA 7 0.0149
20 RESTING TREMOR 9 0.0139
21 GLOMERULONEPHRITIS MINIMAL LESION 10 0.0138
22 VASCULAR PURPURA 19 0.0136
23 LACTIC ACIDOSIS 423 0.0130
24 ABDOMINAL CAVITY DRAINAGE 5 0.0118
25 DIABETIC HYPEROSMOLAR COMA 5 0.0116
26 URINE LEUKOCYTE ESTERASE POSITIVE 8 0.0114
27 GLOMERULOSCLEROSIS 7 0.0111
28 GLOMERULONEPHRITIS MEMBRANOUS 13 0.0111
29 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 9 0.0107
30 ADENOMA BENIGN 9 0.0105
31 INTESTINAL PSEUDO-OBSTRUCTION 9 0.0102
32 CELL DEATH 20 0.0101
33 PEMPHIGOID 76 0.0101
34 RENAL ABSCESS 8 0.0098
35 CHONDROCALCINOSIS PYROPHOSPHATE 7 0.0091
36 RENAL APLASIA 6 0.0085
37 EUGLYCAEMIC DIABETIC KETOACIDOSIS 34 0.0082
38 PERICARDIAL HAEMORRHAGE 18 0.0082
39 SPONTANEOUS HAEMATOMA 6 0.0080
40 SKIN SENSITISATION 8 0.0077
41 ACUTE LEFT VENTRICULAR FAILURE 5 0.0074
42 GLYCOSURIA 10 0.0074
43 DIABETES MELLITUS INADEQUATE CONTROL 130 0.0073
44 HAEMOGLOBINURIA 8 0.0071
45 SUPRAVENTRICULAR EXTRASYSTOLES 24 0.0071
46 LEUKOCYTOCLASTIC VASCULITIS 11 0.0068
47 ANION GAP INCREASED 9 0.0067
48 HYPERPLASIA 6 0.0067
49 HYPOGLYCAEMIC SEIZURE 6 0.0066
50 SHOCK HAEMORRHAGIC 53 0.0065
51 COAGULATION TEST ABNORMAL 5 0.0065
52 URINE KETONE BODY PRESENT 10 0.0063
53 DERMATITIS EXFOLIATIVE GENERALISED 22 0.0063
54 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 11 0.0062
55 PYELONEPHRITIS ACUTE 12 0.0061
56 DEVICE RELATED THROMBOSIS 6 0.0061
57 PYURIA 6 0.0061
58 ANAEMIA HAEMOLYTIC AUTOIMMUNE 5 0.0060
59 SOPOR 80 0.0060
60 HYPERKALAEMIA 211 0.0060
61 TESTICULAR DISORDER 6 0.0060
62 CEREBELLAR SYNDROME 13 0.0059
63 CALCULUS BLADDER 8 0.0059
64 WRONG PATIENT RECEIVED PRODUCT 17 0.0058
65 RENAL TUBULAR INJURY 7 0.0058
66 DIABETIC METABOLIC DECOMPENSATION 8 0.0058
67 BRADYARRHYTHMIA 9 0.0055
68 INTRA-ABDOMINAL HAEMORRHAGE 13 0.0055
69 NORMOCYTIC ANAEMIA 8 0.0054
70 CEREBRAL HAEMATOMA 18 0.0054
71 PANCREATIC CYST 10 0.0052
72 BRADYPHRENIA 34 0.0052
73 HYPOCOAGULABLE STATE 5 0.0051
74 DIABETIC NEPHROPATHY 11 0.0050
75 NEPHROGENIC ANAEMIA 23 0.0050
76 METABOLIC SYNDROME 8 0.0049
77 XEROSIS 6 0.0048
78 KOUNIS SYNDROME 11 0.0048
79 HEPATITIS ACUTE 31 0.0048
80 HEPATITIS FULMINANT 14 0.0047
81 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
82 EXPOSURE TO SARS-COV-2 8 0.0047
83 CORONAVIRUS INFECTION 31 0.0047
84 GASTROINTESTINAL WALL THICKENING 7 0.0047
85 GALLBLADDER ENLARGEMENT 5 0.0046
86 CONTRAINDICATION TO MEDICAL TREATMENT 7 0.0046
87 POLYMYOSITIS 8 0.0045
88 POTENTIATING DRUG INTERACTION 15 0.0045
89 GASTROINTESTINAL STOMA COMPLICATION 7 0.0045
90 HYPERPARATHYROIDISM SECONDARY 11 0.0044
91 ACUTE PRERENAL FAILURE 5 0.0043
92 EPIDIDYMITIS 5 0.0043
93 HYPERGLYCAEMIA 156 0.0043
94 ISCHAEMIC CARDIOMYOPATHY 13 0.0042
95 ANURIA 36 0.0042
96 HAEMATOMA MUSCLE 5 0.0042
97 ISCHAEMIC STROKE 74 0.0041
98 FOOD AVERSION 7 0.0041
99 HENOCH-SCHONLEIN PURPURA 9 0.0041
100 PANCREATIC ENZYMES INCREASED 6 0.0041
101 OCCULT BLOOD POSITIVE 8 0.0041
102 PANCREATITIS ACUTE 91 0.0040
103 ACUTE KIDNEY INJURY 613 0.0040
104 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0040
105 REBOUND ACID HYPERSECRETION 12 0.0040
106 HEPATOCELLULAR INJURY 56 0.0039
107 GLUCOSE URINE PRESENT 5 0.0039
108 ADENOCARCINOMA PANCREAS 5 0.0039
109 PANCREATIC CARCINOMA METASTATIC 11 0.0039
110 PNEUMONIA KLEBSIELLA 7 0.0038
111 HYPERTHERMIA 29 0.0038
112 ANAEMIA MACROCYTIC 8 0.0037
113 MUSCLE HAEMORRHAGE 15 0.0037
114 LEFT VENTRICULAR DYSFUNCTION 25 0.0037
115 HEPATIC NEOPLASM 12 0.0037
116 LINEAR IGA DISEASE 6 0.0036
117 BLOOD LACTIC ACID INCREASED 19 0.0036
118 BLOOD GLUCOSE FLUCTUATION 39 0.0036
119 BUNDLE BRANCH BLOCK LEFT 15 0.0035
120 HYPOMAGNESAEMIA 49 0.0035
121 INJECTION SITE HYPERSENSITIVITY 11 0.0035
122 BLADDER NEOPLASM 6 0.0035
123 ORTHOPNOEA 11 0.0035
124 HYPERSENSITIVITY VASCULITIS 9 0.0034
125 CAPILLARY LEAK SYNDROME 7 0.0034
126 PYELONEPHRITIS 29 0.0033
127 ANAL INCONTINENCE 30 0.0033
128 METABOLIC ACIDOSIS 106 0.0033
129 CYTOLYTIC HEPATITIS 11 0.0033
130 EOSINOPHILIA 58 0.0033
131 ATRIOVENTRICULAR BLOCK COMPLETE 22 0.0033
132 ACUTE CORONARY SYNDROME 27 0.0033
133 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 8 0.0032
134 CHOLESTASIS 61 0.0032
135 HYPOPROTEINAEMIA 6 0.0032
136 HYPOVOLAEMIC SHOCK 15 0.0031
137 NOCARDIOSIS 8 0.0031
138 CUTANEOUS LUPUS ERYTHEMATOSUS 6 0.0031
139 ABDOMINAL WALL HAEMATOMA 6 0.0031
140 HYPOGLYCAEMIC UNCONSCIOUSNESS 6 0.0030
141 NEUROLOGICAL DECOMPENSATION 7 0.0030
142 CUTANEOUS VASCULITIS 11 0.0030
143 RASH MACULO-PAPULAR 67 0.0030
144 EXTRASYSTOLES 21 0.0030
145 LIPASE INCREASED 23 0.0030
146 HYPERLACTACIDAEMIA 8 0.0030
147 KLEBSIELLA INFECTION 15 0.0030
148 HEPATIC CYST 10 0.0029
149 LACUNAR INFARCTION 7 0.0029
150 AUTOIMMUNE HAEMOLYTIC ANAEMIA 10 0.0029
151 HYPOCALCAEMIA 55 0.0029
152 DRUG INTERACTION 458 0.0029
153 PSYCHOMOTOR RETARDATION 8 0.0028
154 DRUG LEVEL ABOVE THERAPEUTIC 13 0.0028
155 DUODENAL ULCER 20 0.0028
156 LIP OEDEMA 12 0.0028
157 BLOOD PRESSURE SYSTOLIC ABNORMAL 7 0.0028
158 DIABETIC KETOACIDOSIS 68 0.0028
159 AGRANULOCYTOSIS 52 0.0028
160 HYPERPHOSPHATAEMIA 6 0.0028
161 GLYCOSYLATED HAEMOGLOBIN INCREASED 70 0.0028
162 LABYRINTHITIS 7 0.0028
163 HAEMODIALYSIS 23 0.0027
164 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 9 0.0027
165 RETROPERITONEAL HAEMATOMA 6 0.0027
166 HEPATIC CYTOLYSIS 34 0.0027
167 MIXED LIVER INJURY 8 0.0027
168 ECCHYMOSIS 18 0.0026
169 DERMATITIS EXFOLIATIVE 13 0.0026
170 RALES 15 0.0026
171 TOXIC SKIN ERUPTION 26 0.0026
172 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 66 0.0026
173 APLASIA 5 0.0026
174 ALTERED STATE OF CONSCIOUSNESS 55 0.0025
175 VENTRICULAR FIBRILLATION 28 0.0025
176 MELAENA 55 0.0025
177 NEPHROTIC SYNDROME 17 0.0025
178 VITAMIN B12 DEFICIENCY 10 0.0025
179 HYPOTHERMIA 25 0.0025
180 TUBULOINTERSTITIAL NEPHRITIS 46 0.0025
181 PSEUDOMONAS INFECTION 21 0.0024
182 PERIPHERAL ISCHAEMIA 10 0.0024
183 COMA SCALE ABNORMAL 7 0.0024
184 NEPHRITIS 8 0.0024
185 RENAL FAILURE ACUTE 101 0.0024
186 NEPHROPATHY 22 0.0024
187 FEBRILE BONE MARROW APLASIA 10 0.0024
188 DERMATITIS BULLOUS 17 0.0023
189 CARDIAC FAILURE CHRONIC 10 0.0023
190 URINE ANALYSIS ABNORMAL 7 0.0023
191 BLOOD CHLORIDE DECREASED 6 0.0023
192 DIABETIC FOOT 7 0.0023
193 PURPURA 20 0.0023
194 CHOLESTATIC LIVER INJURY 5 0.0022
195 TRIGEMINAL NEURALGIA 9 0.0022
196 DRUG LEVEL INCREASED 37 0.0022
197 BLOOD CREATININE DECREASED 7 0.0022
198 GASTROINTESTINAL HYPOMOTILITY 5 0.0022
199 GAMMA-GLUTAMYLTRANSFERASE INCREASED 49 0.0022
200 PROTEIN URINE PRESENT 11 0.0022
201 HYPERURICAEMIA 9 0.0022
202 FOOD INTOLERANCE 8 0.0022
203 SINUS BRADYCARDIA 21 0.0022
204 YELLOW SKIN 10 0.0021
205 BENIGN PROSTATIC HYPERPLASIA 11 0.0021
206 ESCHERICHIA URINARY TRACT INFECTION 9 0.0021
207 APLASTIC ANAEMIA 11 0.0021
208 RHABDOMYOLYSIS 86 0.0021
209 DIABETIC RETINOPATHY 7 0.0021
210 NOCTURIA 25 0.0021
211 INTERNATIONAL NORMALISED RATIO ABNORMAL 7 0.0020
212 ARTERIAL OCCLUSIVE DISEASE 16 0.0020
213 RESPIRATORY ACIDOSIS 8 0.0020
214 LEFT VENTRICULAR FAILURE 7 0.0020
215 PANCREATIC DISORDER 10 0.0020
216 LYMPHOEDEMA 14 0.0020
217 POLYMENORRHOEA 7 0.0020
218 ATYPICAL PNEUMONIA 6 0.0020
219 BLOOD GLUCOSE ABNORMAL 37 0.0020
220 NORMOCHROMIC NORMOCYTIC ANAEMIA 6 0.0020
221 HYPERKERATOSIS 11 0.0020
222 CORONARY ARTERY STENOSIS 10 0.0020
223 NECROSIS 11 0.0020
224 IMMUNE THROMBOCYTOPENIA 9 0.0020
225 ACUTE PULMONARY OEDEMA 11 0.0020
226 ENCEPHALOPATHY 48 0.0020
227 RENAL FAILURE CHRONIC 15 0.0019
228 URINE OUTPUT DECREASED 17 0.0019
229 CEREBRAL ISCHAEMIA 10 0.0019
230 MYOCARDIAL ISCHAEMIA 22 0.0019
231 GASTRITIS EROSIVE 9 0.0019
232 CARDIAC FAILURE 155 0.0019
233 BLOOD PRESSURE DIASTOLIC DECREASED 14 0.0019
234 POLYMYALGIA RHEUMATICA 6 0.0019
235 CHRONIC SINUSITIS 7 0.0019
236 PORTAL VEIN THROMBOSIS 6 0.0019
237 CATHETER SITE INFECTION 7 0.0018
238 ATRIOVENTRICULAR BLOCK FIRST DEGREE 8 0.0018
239 MYOCLONUS 22 0.0018
240 FACE INJURY 7 0.0018
241 BACTERIAL SEPSIS 6 0.0018
242 SEPTIC SHOCK 80 0.0018
243 HAEMODYNAMIC INSTABILITY 14 0.0018
244 TONGUE OEDEMA 7 0.0018
245 RENAL TUBULAR NECROSIS 18 0.0018
246 DYSARTHRIA 68 0.0018
247 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 14 0.0018
248 HYPERAMMONAEMIA 9 0.0018
249 THERAPEUTIC AGENT TOXICITY 6 0.0018
250 TRANSAMINASES INCREASED 40 0.0018
251 HYPERTENSIVE CRISIS 20 0.0018
252 MUSCLE RUPTURE 7 0.0018
253 HAEMOLYTIC ANAEMIA 16 0.0018
254 HAEMATURIA 61 0.0018
255 HAEMATOMA 46 0.0018
256 OLIGURIA 11 0.0018
257 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 9 0.0018
258 INTERNATIONAL NORMALISED RATIO INCREASED 50 0.0018
259 AZOTAEMIA 7 0.0018
260 APLASIA PURE RED CELL 6 0.0017
261 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
262 BLOOD GLUCOSE DECREASED 83 0.0017
263 HYPERTRANSAMINASAEMIA 12 0.0017
264 ESCHERICHIA SEPSIS 5 0.0017
265 HYPOKINESIA 25 0.0017
266 PERFORMANCE STATUS DECREASED 8 0.0017
267 ACIDOSIS 13 0.0017
268 END STAGE RENAL DISEASE 31 0.0017
269 FACIAL PARESIS 6 0.0017
270 ANGINA UNSTABLE 11 0.0017
271 CONGESTIVE CARDIOMYOPATHY 7 0.0017
272 SUBDURAL HAEMATOMA 24 0.0017
273 BLOOD CULTURE POSITIVE 5 0.0017
274 FACE OEDEMA 28 0.0017
275 CHRONIC KIDNEY DISEASE 125 0.0016
276 VENTRICULAR ARRHYTHMIA 6 0.0016
277 THROMBOCYTOSIS 6 0.0016
278 JAUNDICE 44 0.0016
279 INTESTINAL ISCHAEMIA 9 0.0016
280 RENAL FAILURE 217 0.0016
281 HYPONATRAEMIA 92 0.0016
282 IMMUNE-MEDIATED ENTEROCOLITIS 6 0.0016
283 BODY TEMPERATURE DECREASED 16 0.0016
284 FIBROSIS 5 0.0016
285 HAEMATEMESIS 41 0.0016
286 CHOLANGITIS 10 0.0016
287 BLOOD UREA INCREASED 27 0.0016
288 HAEMORRHAGIC ANAEMIA 7 0.0016
289 DYSLIPIDAEMIA 8 0.0016
290 LUNG DISORDER 77 0.0016
291 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
292 IRON DEFICIENCY 7 0.0016
293 COMA 74 0.0016
294 TACHYPNOEA 21 0.0015
295 BLOOD POTASSIUM INCREASED 25 0.0015
296 URINE ABNORMALITY 7 0.0015
297 BLOOD GLUCOSE INCREASED 290 0.0015
298 PARKINSONISM 15 0.0015
299 HYPERTRIGLYCERIDAEMIA 9 0.0015
300 FAECES SOFT 11 0.0015
301 MOUTH HAEMORRHAGE 11 0.0015
302 ORTHOSTATIC HYPOTENSION 26 0.0015
303 RENAL IMPAIRMENT 124 0.0015
304 HYPOKALAEMIA 68 0.0015
305 KETOACIDOSIS 11 0.0015
306 CARDIOGENIC SHOCK 21 0.0015
307 LARYNGEAL OEDEMA 9 0.0015
308 GASTROINTESTINAL TOXICITY 7 0.0015
309 LEG AMPUTATION 6 0.0015
310 GENERALISED OEDEMA 18 0.0015
311 RASH VESICULAR 7 0.0014
312 MULTIPLE ORGAN DYSFUNCTION SYNDROME 41 0.0014
313 PETECHIAE 15 0.0014
314 CARDIO-RESPIRATORY ARREST 60 0.0014
315 PULMONARY ALVEOLAR HAEMORRHAGE 8 0.0014
316 SKIN PLAQUE 12 0.0014
317 ANAEMIA 271 0.0014
318 GASTRIC ULCER 27 0.0014
319 PROTEINURIA 27 0.0014
320 HEPATITIS 36 0.0014
321 INTERSTITIAL LUNG DISEASE 68 0.0014
322 MEDICATION ERROR 78 0.0014
323 SHOCK 32 0.0014
324 INCOHERENT 9 0.0014
325 ENTEROCOLITIS 8 0.0014
326 BLOOD URIC ACID INCREASED 8 0.0014
327 TOXIC ENCEPHALOPATHY 7 0.0014
328 METABOLIC DISORDER 8 0.0014
329 DIABETES MELLITUS 105 0.0014
330 HYPERCALCAEMIA 17 0.0014
331 SPUTUM DISCOLOURED 13 0.0014
332 WALKING AID USER 9 0.0014
333 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 12 0.0014
334 POST PROCEDURAL INFECTION 11 0.0014
335 BLOOD CREATININE INCREASED 88 0.0013
336 PANCREATITIS 71 0.0013
337 ODYNOPHAGIA 8 0.0013
338 URINARY TRACT DISORDER 6 0.0013
339 RENAL DISORDER 62 0.0013
340 ULCER HAEMORRHAGE 9 0.0013
341 VASCULAR DEVICE INFECTION 6 0.0013
342 ACUTE MYOCARDIAL INFARCTION 39 0.0013
343 BRADYCARDIA 70 0.0013
344 CONJUNCTIVAL HAEMORRHAGE 5 0.0013
345 MYOCARDITIS 15 0.0013
346 ONYCHOCLASIS 9 0.0013
347 BLOOD THYROID STIMULATING HORMONE INCREASED 12 0.0013
348 UROSEPSIS 12 0.0013
349 DIFFUSE LARGE B-CELL LYMPHOMA 10 0.0013
350 ATRIOVENTRICULAR BLOCK 10 0.0013
351 HYPOALBUMINAEMIA 10 0.0013
352 BLOOD PRESSURE SYSTOLIC INCREASED 25 0.0013
353 EPIGASTRIC DISCOMFORT 5 0.0013
354 DEPRESSED LEVEL OF CONSCIOUSNESS 50 0.0013
355 PRODUCT PRESCRIBING ERROR 30 0.0013
356 CEREBRAL ATROPHY 5 0.0013
357 BLOOD TRIGLYCERIDES INCREASED 22 0.0012
358 UNRESPONSIVE TO STIMULI 32 0.0012
359 ADRENAL INSUFFICIENCY 15 0.0012
360 CHOLECYSTITIS ACUTE 7 0.0012
361 CEREBRAL HAEMORRHAGE 44 0.0012
362 RENAL CELL CARCINOMA 6 0.0012
363 CONFUSIONAL STATE 198 0.0012
364 POLYURIA 10 0.0012
365 OEDEMA PERIPHERAL 148 0.0012
366 MOUTH SWELLING 7 0.0012
367 FLUID INTAKE REDUCED 6 0.0012
368 PNEUMOCYSTIS JIROVECII PNEUMONIA 12 0.0012
369 URINE ODOUR ABNORMAL 7 0.0012
370 BRADYKINESIA 7 0.0012
371 BONE MARROW FAILURE 24 0.0012
372 PANCYTOPENIA 66 0.0012
373 HEMIPARESIS 20 0.0012
374 DEHYDRATION 157 0.0012
375 AORTIC VALVE INCOMPETENCE 5 0.0012
376 BLOOD ALKALINE PHOSPHATASE INCREASED 29 0.0012
377 BLOOD SODIUM DECREASED 22 0.0012
378 CACHEXIA 6 0.0012
379 FRACTURE 22 0.0012
380 HEPATITIS CHOLESTATIC 7 0.0012
381 PRESCRIBED UNDERDOSE 23 0.0012
382 ANGIOEDEMA 51 0.0012
383 CEREBRAL INFARCTION 28 0.0011
384 ACUTE RESPIRATORY FAILURE 22 0.0011
385 COAGULOPATHY 19 0.0011
386 BLOOD LACTATE DEHYDROGENASE INCREASED 18 0.0011
387 SKIN REACTION 16 0.0011
388 THROMBOTIC MICROANGIOPATHY 11 0.0011
389 CATHETERISATION CARDIAC 5 0.0011
390 HYPOTHYROIDISM 36 0.0011
391 ASCITES 33 0.0011
392 DISORIENTATION 44 0.0011
393 DEVICE RELATED INFECTION 17 0.0011
394 RASH PUSTULAR 8 0.0011
395 HAEMOGLOBIN INCREASED 5 0.0011
396 CHOLECYSTITIS 13 0.0011
397 ATRIAL FIBRILLATION 106 0.0011
398 ANOREXIA 14 0.0011
399 IRON DEFICIENCY ANAEMIA 10 0.0011
400 CYANOSIS 17 0.0011
401 ASPARTATE AMINOTRANSFERASE INCREASED 56 0.0011
402 DERMATITIS CONTACT 12 0.0011
403 CARDIAC FAILURE ACUTE 7 0.0010
404 CARDIAC VALVE DISEASE 6 0.0010
405 RENAL PAIN 11 0.0010
406 METASTASES TO LYMPH NODES 7 0.0010
407 WRONG PRODUCT ADMINISTERED 7 0.0010
408 ABNORMAL LOSS OF WEIGHT 7 0.0010
409 HAEMORRHOIDAL HAEMORRHAGE 5 0.0010
410 CYTOMEGALOVIRUS INFECTION 17 0.0010
411 ELECTROCARDIOGRAM ABNORMAL 8 0.0010
412 C-REACTIVE PROTEIN INCREASED 37 0.0010
413 RESPIRATORY RATE INCREASED 9 0.0010
414 PLEURISY 6 0.0010
415 FOOT OPERATION 5 0.0010
416 HYPOTENSION 202 0.0010
417 LOSS OF CONSCIOUSNESS 129 0.0010
418 AUTOIMMUNE HEPATITIS 7 0.0010
419 ATRIAL FLUTTER 8 0.0010
420 PLEURAL EFFUSION 61 0.0010
421 TRANSPLANT REJECTION 8 0.0010
422 BLOOD DISORDER 8 0.0010
423 HEART RATE DECREASED 35 0.0010
424 TYPE 1 DIABETES MELLITUS 6 0.0010
425 FOOT DEFORMITY 11 0.0010
426 LYMPHOPENIA 14 0.0010
427 STEVENS-JOHNSON SYNDROME 22 0.0010
428 RETINAL HAEMORRHAGE 7 0.0010
429 METASTASIS 7 0.0010
430 RETINAL DETACHMENT 9 0.0010
431 GENERAL PHYSICAL HEALTH DETERIORATION 113 0.0010
432 CARDIOMEGALY 12 0.0010
433 CHROMATURIA 22 0.0010
434 BLOOD CREATINE PHOSPHOKINASE INCREASED 28 0.0010
435 VENTRICULAR TACHYCARDIA 16 0.0010
436 HYPOXIA 34 0.0010
437 HEPATIC ENCEPHALOPATHY 9 0.0010
438 HEPATIC FAILURE 29 0.0010
439 LYMPHOCYTE COUNT DECREASED 17 0.0010
440 ALANINE AMINOTRANSFERASE INCREASED 59 0.0010
441 GASTROENTERITIS 14 0.0010
442 DRUG ERUPTION 17 0.0010
443 ARTERIOSCLEROSIS 9 0.0010
444 FLATULENCE 54 0.0010
445 POISONING DELIBERATE 9 0.0009
446 HALLUCINATION, VISUAL 20 0.0009
447 SUDDEN DEATH 10 0.0009
448 OXYGEN SATURATION DECREASED 53 0.0009
449 HYPOPHAGIA 24 0.0009
450 BODY HEIGHT DECREASED 10 0.0009
451 PROCTALGIA 6 0.0009
452 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 7 0.0009
453 APHASIA 28 0.0009
454 TOXIC EPIDERMAL NECROLYSIS 14 0.0009
455 HEPATOCELLULAR CARCINOMA 7 0.0009
456 SKIN LACERATION 10 0.0009
457 ELECTROCARDIOGRAM QT PROLONGED 33 0.0009
458 BLOOD PRESSURE FLUCTUATION 22 0.0009
459 METASTASES TO LIVER 16 0.0009
460 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0009
461 LIMB DISCOMFORT 28 0.0009
462 GASTRIC ULCER HAEMORRHAGE 5 0.0009
463 URINARY RETENTION 30 0.0009
464 HEPATOTOXICITY 20 0.0009
465 HAEMORRHAGIC STROKE 7 0.0009
466 THROMBOCYTOPENIA 100 0.0009
467 MALNUTRITION 10 0.0009
468 EMPHYSEMA 9 0.0009
469 CORONARY ARTERY DISEASE 27 0.0009
470 INJECTION SITE EXTRAVASATION 11 0.0009
471 NEPHROPATHY TOXIC 10 0.0009
472 PRODUCT ADMINISTRATION ERROR 18 0.0009
473 CANDIDA INFECTION 15 0.0009
474 BLOOD ALBUMIN DECREASED 7 0.0009
475 TRICUSPID VALVE INCOMPETENCE 7 0.0009
476 SYNCOPE 88 0.0009
477 SCIATICA 14 0.0009
478 INFARCTION 6 0.0009
479 HAEMOGLOBIN DECREASED 90 0.0009
480 PULMONARY MASS 13 0.0009
481 ANGINA PECTORIS 25 0.0009
482 TEMPERATURE INTOLERANCE 9 0.0009
483 PNEUMONIA BACTERIAL 8 0.0009
484 METASTASES TO LUNG 10 0.0009
485 DECUBITUS ULCER 7 0.0009
486 BLOOD PRESSURE ABNORMAL 17 0.0009
487 HYPOVOLAEMIA 5 0.0009
488 ABNORMAL FAECES 7 0.0009
489 COLD SWEAT 15 0.0009
490 LACERATION 8 0.0008
491 DIALYSIS 12 0.0008
492 BACTERAEMIA 10 0.0008
493 PNEUMONIA ASPIRATION 21 0.0008
494 ANKLE FRACTURE 13 0.0008
495 BLOOD PRESSURE INADEQUATELY CONTROLLED 5 0.0008
496 GLAUCOMA 16 0.0008
497 FALL 275 0.0008
498 PRESYNCOPE 20 0.0008
499 RECTAL HAEMORRHAGE 35 0.0008
500 MYOPATHY 7 0.0008
501 RENAL INJURY 24 0.0008
502 IMPAIRED GASTRIC EMPTYING 11 0.0008
503 BLADDER DISORDER 8 0.0008
504 EXTRAPYRAMIDAL DISORDER 20 0.0008
505 HEPATIC STEATOSIS 15 0.0008
506 HEPATIC FUNCTION ABNORMAL 30 0.0008
507 BLOOD CALCIUM DECREASED 9 0.0008
508 BRAIN INJURY 8 0.0008
509 MITRAL VALVE INCOMPETENCE 9 0.0008
510 POLLAKIURIA 33 0.0008
511 HAEMOPTYSIS 22 0.0008
512 TASTE DISORDER 16 0.0008
513 STAPHYLOCOCCAL INFECTION 26 0.0008
514 ASTHENIA 295 0.0008
515 GOUT 14 0.0008
516 BLOOD BILIRUBIN INCREASED 21 0.0008
517 ELECTROLYTE IMBALANCE 9 0.0008
518 HYPERPROLACTINAEMIA 5 0.0008
519 VENTRICULAR EXTRASYSTOLES 8 0.0008
520 DYSPNOEA EXERTIONAL 29 0.0008
521 WEIGHT FLUCTUATION 8 0.0008
522 PARAESTHESIA ORAL 11 0.0008
523 ARRHYTHMIA 36 0.0008
524 TOXICITY TO VARIOUS AGENTS 128 0.0008
525 RENAL CYST 6 0.0008
526 FEBRILE NEUTROPENIA 50 0.0008
527 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
528 RESPIRATORY FAILURE 53 0.0007
529 PRESCRIBED OVERDOSE 14 0.0007
530 DECREASED APPETITE 168 0.0007
531 VERTIGO 44 0.0007
532 HEMIPLEGIA 6 0.0007
533 OSTEOMYELITIS 13 0.0007
534 URINARY TRACT INFECTION 122 0.0007
535 TREATMENT NONCOMPLIANCE 39 0.0007
536 TRANSIENT ISCHAEMIC ATTACK 24 0.0007
537 BLOOD PRESSURE DECREASED 47 0.0007
538 DYSURIA 26 0.0007
539 GASTROINTESTINAL HAEMORRHAGE 59 0.0007
540 SINUS TACHYCARDIA 10 0.0007
541 ABDOMINAL PAIN 163 0.0007
542 DIARRHOEA 451 0.0007
543 INFUSION SITE PAIN 9 0.0007
544 RESPIRATORY TRACT INFECTION 18 0.0007
545 SEPSIS 77 0.0007
546 EYELID OEDEMA 8 0.0007
547 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
548 COLITIS 26 0.0007
549 APATHY 10 0.0007
550 GASTRITIS 18 0.0007
551 TUMOUR LYSIS SYNDROME 6 0.0007
552 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
553 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
554 BLOOD IRON DECREASED 8 0.0007
555 COLON CANCER 10 0.0007
556 HYPERLIPIDAEMIA 8 0.0007
557 NEUTROPENIA 91 0.0007
558 MUSCULAR WEAKNESS 76 0.0007
559 MYOSITIS 6 0.0007
560 TRANSFUSION 7 0.0007
561 OROPHARYNGEAL DISCOMFORT 6 0.0007
562 HEART RATE IRREGULAR 15 0.0007
563 INTESTINAL OBSTRUCTION 25 0.0007
564 PSYCHOMOTOR HYPERACTIVITY 11 0.0007
565 NEUTROPHIL COUNT DECREASED 27 0.0007
566 LEUKOPENIA 33 0.0007
567 CYSTITIS 21 0.0007
568 CARDIAC ARREST 54 0.0007
569 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
570 NERVE COMPRESSION 6 0.0006
571 PRODUCTIVE COUGH 31 0.0006
572 OEDEMA 35 0.0006
573 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
574 ILEUS 8 0.0006
575 FLANK PAIN 6 0.0006
576 BLINDNESS UNILATERAL 9 0.0006
577 DRUG-INDUCED LIVER INJURY 20 0.0006
578 GASTROINTESTINAL PAIN 7 0.0006
579 LEUKAEMIA 6 0.0006
580 CARDIAC FAILURE CONGESTIVE 51 0.0006
581 DELIRIUM 22 0.0006
582 RED BLOOD CELL SEDIMENTATION RATE INCREASED 7 0.0006
583 ACCIDENTAL OVERDOSE 23 0.0006
584 EPISTAXIS 47 0.0006
585 HYPERTENSION 133 0.0006
586 CONTRAINDICATED PRODUCT ADMINISTERED 19 0.0006
587 LIMB INJURY 17 0.0006
588 TYPE 2 DIABETES MELLITUS 21 0.0006
589 VOMITING 293 0.0006
590 MYELODYSPLASTIC SYNDROME 9 0.0006
591 PULMONARY ARTERIAL HYPERTENSION 9 0.0006
592 HYPERHIDROSIS 80 0.0006
593 DYSPNOEA 351 0.0006
594 LIVER FUNCTION TEST ABNORMAL 18 0.0006
595 PNEUMONIA 199 0.0006
596 CONSTIPATION 134 0.0006
597 MENTAL STATUS CHANGES 17 0.0006
598 LIVER INJURY 15 0.0006
599 HICCUPS 5 0.0006
600 GASTRIC HAEMORRHAGE 7 0.0006
601 BRONCHITIS 45 0.0006
602 PHOTOSENSITIVITY REACTION 10 0.0006
603 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
604 WEIGHT DECREASED 168 0.0006
605 COGNITIVE DISORDER 28 0.0006
606 WHITE BLOOD CELL COUNT INCREASED 23 0.0006
607 PRODUCT DISPENSING ERROR 13 0.0006
608 EYELID PTOSIS 6 0.0006
609 DRY THROAT 6 0.0006
610 MIDDLE INSOMNIA 11 0.0006
611 PYREXIA 203 0.0006
612 HELICOBACTER INFECTION 6 0.0006
613 CHEST PAIN 108 0.0006
614 PROSTATIC SPECIFIC ANTIGEN INCREASED 8 0.0006
615 BLOOD URINE PRESENT 11 0.0006
616 BLOOD MAGNESIUM DECREASED 5 0.0006
617 HYPERBILIRUBINAEMIA 6 0.0006
618 MULTI-ORGAN FAILURE 10 0.0006
619 MUCOSAL INFLAMMATION 15 0.0006
620 CARPAL TUNNEL SYNDROME 8 0.0006
621 FLUID RETENTION 29 0.0006
622 MOUTH ULCERATION 12 0.0006
623 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
624 OSTEONECROSIS OF JAW 14 0.0006
625 PERICARDIAL EFFUSION 13 0.0006
626 INFLAMMATION 29 0.0006
627 CARDIOTOXICITY 5 0.0006
628 SECRETION DISCHARGE 7 0.0006
629 HAEMARTHROSIS 5 0.0006
630 BALANCE DISORDER 48 0.0006
631 PANCREATIC CARCINOMA 16 0.0006
632 PLATELET COUNT DECREASED 59 0.0006
633 FAECES DISCOLOURED 12 0.0006
634 HYPERTHYROIDISM 8 0.0006
635 PNEUMONITIS 15 0.0006
636 PRODUCT PRESCRIBING ISSUE 12 0.0006
637 NEEDLE ISSUE 16 0.0005
638 ABDOMINAL DISTENSION 57 0.0005
639 INTENTIONAL OVERDOSE 35 0.0005
640 INJECTION SITE NODULE 6 0.0005
641 ANAPHYLACTIC SHOCK 14 0.0005
642 DISCOMFORT 33 0.0005
643 ERYTHEMA MULTIFORME 5 0.0005
644 APPENDICITIS 5 0.0005
645 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
646 FISTULA 6 0.0005
647 PULMONARY CONGESTION 7 0.0005
648 HALLUCINATION 40 0.0005
649 BLOOD PRESSURE INCREASED 81 0.0005
650 HEPATIC ENZYME INCREASED 36 0.0005
651 PULMONARY HYPERTENSION 11 0.0005
652 HAEMATOTOXICITY 5 0.0005
653 INTENTIONAL PRODUCT MISUSE 46 0.0005
654 EYE HAEMORRHAGE 7 0.0005
655 GAIT DISTURBANCE 100 0.0005
656 JOINT RANGE OF MOTION DECREASED 7 0.0005
657 DRUG PRESCRIBING ERROR 10 0.0005
658 DISTURBANCE IN ATTENTION 28 0.0005
659 VISUAL IMPAIRMENT 64 0.0005
660 DYSPHAGIA 49 0.0005
661 DIZZINESS POSTURAL 5 0.0005
662 PRURITUS 198 0.0005
663 VASCULITIS 6 0.0005
664 EJECTION FRACTION DECREASED 8 0.0005
665 DYSSTASIA 15 0.0005
666 ACUTE MYELOID LEUKAEMIA 8 0.0005
667 BASAL CELL CARCINOMA 8 0.0005
668 PERIPHERAL COLDNESS 7 0.0005
669 MALAISE 223 0.0005
670 COVID-19 PNEUMONIA 6 0.0005
671 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
672 ATAXIA 6 0.0005
673 DIVERTICULITIS 14 0.0005
674 HAEMATOCRIT DECREASED 10 0.0005
675 LEUKOCYTOSIS 9 0.0005
676 TOOTHACHE 9 0.0005
677 ORAL PAIN 11 0.0005
678 PARALYSIS 7 0.0005
679 SMALL INTESTINAL OBSTRUCTION 6 0.0005
680 METASTASES TO BONE 8 0.0005
681 ACCIDENTAL UNDERDOSE 7 0.0005
682 OSTEOPOROSIS 20 0.0005
683 FUNGAL INFECTION 16 0.0005
684 BRAIN OEDEMA 6 0.0005
685 PULMONARY EMBOLISM 45 0.0005
686 RESPIRATORY ARREST 13 0.0005
687 RESPIRATORY DISTRESS 13 0.0005
688 CONDITION AGGRAVATED 143 0.0005
689 CIRCULATORY COLLAPSE 8 0.0005
690 PULMONARY FIBROSIS 9 0.0005
691 MALIGNANT NEOPLASM PROGRESSION 48 0.0005
692 RESPIRATORY DISORDER 14 0.0005
693 DYSKINESIA 19 0.0005
694 HIP FRACTURE 15 0.0005
695 ERUCTATION 9 0.0005
696 AGITATION 34 0.0005
697 SUICIDE ATTEMPT 28 0.0005
698 DEEP VEIN THROMBOSIS 30 0.0005
699 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
700 FEELING HOT 28 0.0005
701 NEUROTOXICITY 8 0.0005
702 LOCALISED INFECTION 11 0.0005
703 RED BLOOD CELL COUNT DECREASED 13 0.0005
704 INFUSION RELATED REACTION 30 0.0005
705 MUSCULOSKELETAL CHEST PAIN 7 0.0005
706 TENDONITIS 7 0.0005
707 SOMNOLENCE 91 0.0005
708 ABDOMINAL PAIN UPPER 93 0.0005
709 LUNG INFECTION 7 0.0005
710 THERAPY PARTIAL RESPONDER 7 0.0004
711 MALIGNANT MELANOMA 6 0.0004
712 THIRST 8 0.0004
713 PULMONARY OEDEMA 20 0.0004
714 DIZZINESS 222 0.0004
715 PRODUCT TASTE ABNORMAL 6 0.0004
716 HEAD INJURY 14 0.0004
717 PALLOR 12 0.0004
718 ULCER 7 0.0004
719 GINGIVAL BLEEDING 6 0.0004
720 ABSCESS 7 0.0004
721 RIB FRACTURE 9 0.0004
722 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
723 CATARACT 26 0.0004
724 LETHARGY 25 0.0004
725 INJECTION SITE MASS 16 0.0004
726 PREMATURE BABY 13 0.0004
727 ORAL DISCOMFORT 6 0.0004
728 OVERDOSE 93 0.0004
729 HUNGER 6 0.0004
730 COORDINATION ABNORMAL 6 0.0004
731 DEMENTIA 12 0.0004
732 MASS 6 0.0004
733 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
734 LIVER DISORDER 19 0.0004
735 DYSPHONIA 25 0.0004
736 EYE DISORDER 14 0.0004
737 HEPATIC CIRRHOSIS 8 0.0004
738 SKIN ULCER 11 0.0004
739 DRUG INTOLERANCE 41 0.0004
740 DRUG ADMINISTRATION ERROR 13 0.0004
741 SPEECH DISORDER 22 0.0004
742 WEIGHT INCREASED 94 0.0004
743 SKIN DISORDER 14 0.0004
744 RASH ERYTHEMATOUS 20 0.0004
745 BLINDNESS 17 0.0004
746 TREMOR 69 0.0004
747 WHITE BLOOD CELL COUNT DECREASED 45 0.0004
748 GASTROINTESTINAL DISORDER 37 0.0004
749 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
750 NAUSEA 326 0.0004
751 UNDERDOSE 30 0.0004
752 HAEMORRHOIDS 8 0.0004
753 TACHYCARDIA 36 0.0004
754 CONTUSION 39 0.0004
755 RASH PAPULAR 9 0.0004
756 INJECTION SITE HAEMORRHAGE 32 0.0004
757 HERPES ZOSTER 23 0.0004
758 INTENTIONAL PRODUCT USE ISSUE 35 0.0004
759 NEUROPATHY PERIPHERAL 38 0.0004
760 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
761 DISEASE PROGRESSION 47 0.0004
762 CELLULITIS 20 0.0004
763 ECONOMIC PROBLEM 6 0.0004
764 STOMATITIS 24 0.0004
765 HEAD DISCOMFORT 7 0.0004
766 FEEDING DISORDER 8 0.0004
767 GALLBLADDER DISORDER 7 0.0004
768 CHEST DISCOMFORT 40 0.0004
769 PAIN IN EXTREMITY 115 0.0004
770 HIATUS HERNIA 5 0.0004
771 RASH GENERALISED 10 0.0004
772 PALPITATIONS 45 0.0004
773 SWOLLEN TONGUE 12 0.0004
774 HAEMORRHAGE 40 0.0004
775 RESTLESSNESS 14 0.0004
776 DEAFNESS 10 0.0004
777 URTICARIA 64 0.0004
778 PNEUMOTHORAX 6 0.0004
779 OSTEOARTHRITIS 16 0.0004
780 BACTERIAL INFECTION 7 0.0004
781 NIGHT SWEATS 12 0.0004
782 HYPOACUSIS 16 0.0004
783 MENTAL IMPAIRMENT 9 0.0004
784 PRURITUS GENERALISED 8 0.0004
785 MENTAL DISORDER 16 0.0004
786 COUGH 103 0.0004
787 DRUG TOXICITY 5 0.0004
788 FATIGUE 285 0.0004
789 CHOLELITHIASIS 12 0.0004
790 ACUTE HEPATIC FAILURE 5 0.0004
791 BLOOD POTASSIUM DECREASED 11 0.0004
792 ERYTHEMA 75 0.0004
793 PRODUCT SUBSTITUTION ISSUE 21 0.0004
794 MYALGIA 62 0.0004
795 CORONARY ARTERY OCCLUSION 5 0.0004
796 SKIN LESION 10 0.0004
797 RASH 158 0.0004
798 HAEMATOCHEZIA 20 0.0004
799 FEELING COLD 10 0.0004
800 OCULAR HYPERAEMIA 17 0.0004
801 ABDOMINAL DISCOMFORT 60 0.0004
802 DYSPEPSIA 35 0.0004
803 GYNAECOMASTIA 11 0.0004
804 GASTRIC CANCER 9 0.0004
805 ASTHMA 40 0.0004
806 MUSCULOSKELETAL STIFFNESS 31 0.0004
807 BRONCHOSPASM 5 0.0004
808 BACK PAIN 81 0.0003
809 PRODUCT PHYSICAL ISSUE 7 0.0003
810 OROPHARYNGEAL PAIN 32 0.0003
811 FLUID OVERLOAD 5 0.0003
812 SYRINGE ISSUE 6 0.0003
813 ANHEDONIA 9 0.0003
814 BONE PAIN 20 0.0003
815 NECK PAIN 19 0.0003
816 CARDIOMYOPATHY 5 0.0003
817 KNEE ARTHROPLASTY 7 0.0003
818 CARDIAC DISORDER 31 0.0003
819 PERIPHERAL SWELLING 51 0.0003
820 LIP SWELLING 11 0.0003
821 RESTLESS LEGS SYNDROME 6 0.0003
822 NEURALGIA 8 0.0003
823 EATING DISORDER 7 0.0003
824 POOR QUALITY SLEEP 7 0.0003
825 COVID-19 57 0.0003
826 DYSGEUSIA 24 0.0003
827 FEMUR FRACTURE 10 0.0003
828 OFF LABEL USE 277 0.0003
829 FEELING JITTERY 6 0.0003
830 CONVULSION 18 0.0003
831 NASOPHARYNGITIS 58 0.0003
832 HYPERSOMNIA 9 0.0003
833 COLITIS ULCERATIVE 14 0.0003
834 COMPLETED SUICIDE 26 0.0003
835 MOVEMENT DISORDER 10 0.0003
836 DIPLOPIA 8 0.0003
837 PRODUCT AVAILABILITY ISSUE 7 0.0003
838 SWELLING FACE 20 0.0003
839 CHILLS 36 0.0003
840 NEPHROLITHIASIS 14 0.0003
841 ARTHRITIS 24 0.0003
842 INFLUENZA 34 0.0003
843 IMPAIRED HEALING 10 0.0003
844 URINARY INCONTINENCE 9 0.0003
845 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
846 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
847 BLISTER 17 0.0003
848 EYE PAIN 17 0.0003
849 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 54 0.0003
850 CYTOKINE RELEASE SYNDROME 6 0.0003
851 INSOMNIA 79 0.0003
852 CEREBROVASCULAR ACCIDENT 50 0.0003
853 ARTHRALGIA 122 0.0003
854 AMNESIA 19 0.0003
855 PRODUCT PREPARATION ERROR 6 0.0003
856 INFECTION 42 0.0003
857 THERAPY NON-RESPONDER 13 0.0003
858 SWELLING 27 0.0003
859 DERMATITIS 6 0.0003
860 THROMBOSIS 23 0.0003
861 ABASIA 7 0.0003
862 LYMPHADENOPATHY 10 0.0003
863 ILLNESS 29 0.0003
864 SKIN CANCER 6 0.0003
865 HEART RATE INCREASED 27 0.0003
866 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 13 0.0003
867 MYOCARDIAL INFARCTION 47 0.0003
868 MEMORY IMPAIRMENT 37 0.0003
869 SLEEP DISORDER 19 0.0003
870 LUNG NEOPLASM MALIGNANT 11 0.0003
871 SNEEZING 6 0.0003
872 THROAT IRRITATION 12 0.0003
873 PARAESTHESIA 42 0.0003
874 HYPERSENSITIVITY 49 0.0003
875 EAR INFECTION 7 0.0003
876 VISION BLURRED 36 0.0003
877 ALOPECIA 51 0.0003
878 DYSTONIA 5 0.0003
879 RASH MACULAR 9 0.0003
880 MUSCLE SPASMS 47 0.0003
881 PRODUCT USE ISSUE 48 0.0003
882 INJECTION SITE PAIN 78 0.0003
883 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
884 PROCEDURAL PAIN 7 0.0003
885 NERVOUSNESS 13 0.0002
886 ECZEMA 13 0.0002
887 FULL BLOOD COUNT DECREASED 5 0.0002
888 THERAPEUTIC RESPONSE DECREASED 15 0.0002
889 HYPOAESTHESIA 37 0.0002
890 BREAST CANCER 23 0.0002
891 FLUSHING 25 0.0002
892 VISUAL ACUITY REDUCED 8 0.0002
893 AGEUSIA 6 0.0002
894 JOINT SWELLING 29 0.0002
895 GAIT INABILITY 8 0.0002
896 RHEUMATOID ARTHRITIS 27 0.0002
897 PAIN 146 0.0002
898 ABDOMINAL PAIN LOWER 6 0.0002
899 PROSTATE CANCER 19 0.0002
900 HEADACHE 147 0.0002
901 DRY MOUTH 19 0.0002
902 INCORRECT DOSE ADMINISTERED 53 0.0002
903 DRUG DOSE OMISSION 38 0.0002
904 SEDATION 6 0.0002
905 JOINT STIFFNESS 6 0.0002
906 BURNING SENSATION 16 0.0002
907 DEPRESSED MOOD 12 0.0002
908 PRODUCT USE IN UNAPPROVED INDICATION 56 0.0002
909 INJECTION SITE BRUISING 18 0.0002
910 MOBILITY DECREASED 16 0.0002
911 EXTRA DOSE ADMINISTERED 9 0.0002
912 FREQUENT BOWEL MOVEMENTS 6 0.0002
913 INJECTION SITE SWELLING 17 0.0002
914 MOOD ALTERED 6 0.0002
915 ANAPHYLACTIC REACTION 12 0.0002
916 SINUSITIS 22 0.0002
917 PRODUCT DOSE OMISSION 14 0.0002
918 HOT FLUSH 16 0.0002
919 MUSCULOSKELETAL PAIN 11 0.0002
920 HOSPITALISATION 32 0.0002
921 DEVICE LEAKAGE 9 0.0002
922 ANXIETY 59 0.0002
923 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
924 DRUG INEFFECTIVE 272 0.0002
925 GASTRIC DISORDER 7 0.0002
926 BLADDER CANCER 12 0.0002
927 LABORATORY TEST ABNORMAL 6 0.0002
928 PSYCHOTIC DISORDER 6 0.0002
929 DEATH 175 0.0002
930 NEOPLASM PROGRESSION 7 0.0002
931 ILL-DEFINED DISORDER 12 0.0002
932 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
933 TINNITUS 9 0.0002
934 DRUG RESISTANCE 5 0.0002
935 BLOOD CHOLESTEROL INCREASED 9 0.0002
936 PRODUCT QUALITY ISSUE 26 0.0002
937 DISEASE RECURRENCE 9 0.0002
938 VIRAL INFECTION 6 0.0002
939 DEPRESSION 41 0.0002
940 FEELING ABNORMAL 42 0.0002
941 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
942 RHINORRHOEA 11 0.0002
943 INJECTION SITE ERYTHEMA 21 0.0002
944 THERAPY INTERRUPTED 12 0.0002
945 MULTIPLE SCLEROSIS 8 0.0002
946 DRUG EFFECT DECREASED 9 0.0002
947 ADVERSE DRUG REACTION 15 0.0002
948 RASH PRURITIC 9 0.0002
949 DRY SKIN 22 0.0002
950 INJECTION SITE PRURITUS 11 0.0002
951 EPILEPSY 5 0.0002
952 ARTHROPATHY 9 0.0002
953 PSORIASIS 21 0.0002
954 DRY EYE 8 0.0002
955 INJURY 11 0.0002
956 THERAPY CESSATION 8 0.0002
957 SKIN EXFOLIATION 13 0.0002
958 NASAL CONGESTION 9 0.0002
959 WHEEZING 9 0.0002
960 EXPIRED PRODUCT ADMINISTERED 5 0.0002
961 PRODUCT DOSE OMISSION ISSUE 44 0.0001
962 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 30 0.0001
963 ANGER 5 0.0001
964 SEIZURE 17 0.0001
965 INFLUENZA LIKE ILLNESS 12 0.0001
966 DRUG ABUSE 12 0.0001
967 ROAD TRAFFIC ACCIDENT 6 0.0001
968 WITHDRAWAL SYNDROME 6 0.0001
969 EYE IRRITATION 8 0.0001
970 EYE SWELLING 5 0.0001
971 DEVICE ISSUE 12 0.0001
972 SUICIDAL IDEATION 12 0.0001
973 SKIN DISCOLOURATION 6 0.0001
974 ADVERSE EVENT 12 0.0001
975 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
976 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
977 SURGERY 7 0.0001
978 ACNE 9 0.0001
979 IRRITABILITY 7 0.0001
980 DERMATITIS ATOPIC 6 0.0001
981 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
982 UNEVALUABLE EVENT 8 0.0001
983 MIGRAINE 10 0.0001
984 PRODUCT STORAGE ERROR 9 0.0001
985 INJECTION SITE REACTION 7 0.0001
986 EMOTIONAL DISTRESS 11 0.0001
987 NEOPLASM MALIGNANT 6 0.0001
988 DEVICE MALFUNCTION 6 0.0001
989 FOETAL EXPOSURE DURING PREGNANCY 6 0.0001
990 NO ADVERSE EVENT 10 0.0001